相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
Julia D. Wulfkuhle et al.
CLINICAL CANCER RESEARCH (2012)
Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6
Sanjay Mukhopadhyay et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
Christy C. Ong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Monitoring proteins and protein networks using reverse phase protein arrays
Bridget Wilson et al.
DISEASE MARKERS (2010)
Deciphering Signaling Pathways in Clinical Tissues for Personalized Medicine Using Protein Microarrays
K. Malinowsky et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Antibody-based proteomics
Hans Voshol et al.
FEBS JOURNAL (2009)
Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting
Niroshini J. Nirmalan et al.
JOURNAL OF PATHOLOGY (2009)
Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues
Maria Filippa Addis et al.
PROTEOMICS (2009)
Systematic Review of HER2 Breast Cancer Testing
Marta Cuadros et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
HER2-positive breast cancer: Current treatment strategies
Edith A. Perez et al.
CANCER INVESTIGATION (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
Guided protein extraction from formalin-fixed tissues for quantitative multiplex analysis avoids detrimental effects of histological stains
Karl-Friedrich Becker et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
A well-based reverse-phase protein array applicable to extracts from formalin-fixed paraffin-embedded tissue
Joon-Yong Chung et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 status in adenocarcinoma of the breast - A single institution experience
Raymond R. Tubbs et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2007)
Standardizing slide-based assays in breast cancer: Hormone receptors, HER2, and sentinel lymph nodes
Jeffrey S. Ross et al.
CLINICAL CANCER RESEARCH (2007)
Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis
Nandini Dendukuri et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Quantitative protein analysis from formalin-fixed tissues:: implications for translational clinical research and nanoscale molecular diagnosis
K-F Becker et al.
JOURNAL OF PATHOLOGY (2007)
Protein extraction from formalin-fixed, paraffin-embedded tissue sections: Quality evaluation by mass spectrometry
Shan-Rong Shi et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients
Caroline Holm et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
A nondestructive molecule extraction method allowing morphological and molecular analyses using a single tissue section
WS Chu et al.
LABORATORY INVESTIGATION (2005)
Diagnostic evaluation of HER-2 as a molecular target: An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials
MF Press et al.
CLINICAL CANCER RESEARCH (2005)
HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization - A single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring
P Lal et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Targeted therapy in breast cancer -: The HER-2/neu gene and protein
JS Ross et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Pak-1 expression increases with progression of colorectal carcinomas to metastasis
JH Carter et al.
CLINICAL CANCER RESEARCH (2004)
Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation
R Jakobi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Emerging functions of p21-activated kinases in human cancer cells
R Kumar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Prognostic and predictive value of HER2/neu oncogene in breast cancer
S Masood et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2002)
C-erbB-2 in breast cancer: Development of a clinically useful marker
DF Hayes et al.
SEMINARS IN ONCOLOGY (2002)
HER-2/neu in breast cancer:: Interobserver variability and performance of immunohistochemistry with 4 antibodies compared with fluorescent in situ hybridization
TA Thomson et al.
MODERN PATHOLOGY (2001)
p21-activated protein kinase γ-PAK suppresses programmed cell death of BALB3T3 fibroblasts
R Jakobi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
